ExLibris header image
SFX Logo
Title: Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A
Source:

Molecular and Cellular Biochemistry [0300-8177] Khandelwal, Madhuram yr:2018


Collapse list of basic services Basic
Full text
Full text available via SpringerLINK Contemporary 1997-Present
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Plumb, J A A. "Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter." Cancer research 60.21 (2000): 6039-44. Link to SFX for this item
2. Chowdhury, B. "The hypomethylating agent Decitabine causes a paradoxical increase in 5-hydroxymethylcytosine in human leukemia cells." Scientific Reports 5 (2015): 9281-. Link to Full Text for this item Link to SFX for this item
3. Ballestar, E. "Methyl-CpG-binding proteins." European journal of biochemistry 268.1 (2001): 1-6. Link to Full Text for this item Link to SFX for this item
4. Watanabe, Y. "A change in promoter methylation of hMLH1 is a cause of acquired resistance to platinum-based chemotherapy in epithelial ovarian cancer." Anticancer research 27.3B (2007): 1449-1452. Link to SFX for this item
5. Pegram, M. "Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers." Oncogene 18.13 (1999): 2241-51. Link to Full Text for this item Link to SFX for this item
6. Wang, J. "Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells." Cell cycle 8.19 (2009): 3191-3198. Link to Full Text for this item Link to SFX for this item
7. Beryt, Dennis J D. "Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer." Journal of the National Cancer Institute 96.10 (2004): 739-49. Link to SFX for this item
8. Choudhury, Samrat R. "Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant glioma." Clinical Epigenetics 7.1 (2015): 107-107. Link to Full Text for this item Link to SFX for this item
9. Du, C. "The hENT1 and DCK genes underlie the decitabine response in patients with myelodysplastic syndrome." Leukemia research 39.2 (2015): 216-20. Link to SFX for this item
10. Matei, D. "Epigenetic Targeting of Ovarian Cancer Stem Cells." Cancer research 74.17 (2014): 4922-36. Link to SFX for this item
11. Brown, R. "hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents." Oncogene 15.1 (1997): 45-52. Link to Full Text for this item Link to SFX for this item
12. Ito, S. "Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine." Science 333.6047 (2011): 1300-1303. Link to SFX for this item
13. Quaresima, B. "Human mismatch-repair protein MutL homologue 1 (MLH1) interacts with Escherichia coli MutL and MutS in vivo and in vitro: a simple genetic system to assay MLH1 function." The Biochemical journal 371.Pt 1 (2003): 183-189. Link to Full Text for this item Link to SFX for this item
14. Stewart, Charles L N. "Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer." Journal of clinical oncology 20.3 (2002): 719-26. Link to SFX for this item
15. Stupp, P. "MGMT gene silencing and benefit from temozolomide in glioblastoma." New England Journal of Medicine, The 352.10 (2005): 997-1003. Link to SFX for this item
16. Chou, Ting-Chao C. "Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies." Pharmacological reviews 58.3 (2006): 621-681. Link to SFX for this item
17. Burris, H A A. "Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial." Journal of clinical oncology 15.6 (1997): 2403-13. Link to SFX for this item
18. Kuperwasser, Charlotte M. "Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy." Breast cancer research 10.2 (2008). Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.